Skip to Main Content

Paper Details

Heterogeneity and Clonal Evolution of Acquired PARP Inhibitor Resistance in <i>TP53-</i> and <i>BRCA1</i>-Deficient Cells.
Cancer Res
15
2021
BRCA1, BRCA1-deficient cells, BRCA1-mutant, Cas9, HGSC, Homologous recombination (HR)-deficient cancers, PARP, PARPi, PARPi-resistant clones, PARPi-sensitive TP53 -/- and BRCA1 -/- epithelial cell line, PARPi-sensitive cell line, TP53, TP53- and BRCA1-Deficient Cells, high-grade serous cancers, patient, patients, poly-ADP ribose, poly-ADP ribose polymerase, sensitive cell line, single-cell clones
Author NameAffiliation
Jaana OikkonenUniversity of Helsinki and Helsinki University Hospital
Huy NguyenDana-Farber Cancer Institute, Harvard Medical School
Caitlin E MillsHarvard Medical School
Peter J ParkHarvard Medical School
Peter J ParkHarvard Medical School
Peter K SorgerHarvard Medical School
Alan D D'AndreaDana-Farber Cancer Institute, Harvard Medical School
Alan D D'AndreaDana-Farber Cancer Institute, Harvard Medical School
  • 1 - 8

Datasets

Release 1.2